Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer
Clinical trial NCT02516241 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02516241
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-02
- Primary completion
- 2020-01-27
- Enrollment
- 1126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.